Telos Corp. (TLS)

NASDAQInformation TechnologyInformation Technology ServicesSnapshot 2026-10-23

$4.87+6.56%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Telos Corp.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	45.83M
EPS	—	0.009
Annual ending 2026-12-31
Revenue	—	191.32M
EPS	—	0.156
Annual ending 2027-12-31
Revenue	—	191.99M
EPS	—	0.223

Management figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
CEO John B. Wood maintains full duties	A supporting condition in Telos Corp.'s published investment case. The stated target is CEO remains active in full duties.	Intact	CEO leaves or is unable to perform full duties	CEO active in full duties vs target: active CEO returned from medical leave and resumed full duties in May 2026. No news of departure or incapacity. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated in 2 of last 2 quarters. CEO John B. Wood was on medical leave in 2026-Q1 and returned to full duties by 2026-Q2. This leadership transition is recent and management has emphasized the CEO's return as a priority. The financials show improvement in 2026-Q1 and Q2, consistent with stabilizing leadership. Delivery assessment Oct 24, 2026
EPS growth to $0.26 in FY27	A primary condition in Telos Corp.'s published investment case. The stated target is EPS >= $0.26.	Broken	EPS falls below $0.26 in FY27	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated in 3 of last 3 quarters. Net income improved from a loss of $16.3M in 2025-Q4 to a profit of $2.0M in 2026-Q1. Management has consistently announced earnings beats in press releases, showing delivering operational progress in profitability. Delivery assessment Oct 24, 2026
Revenue growth of about 15% next year	Analysts expect about 15% revenue growth next year.	Intact	YoY revenue growth falls below ~14.8% next year	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Revenue grew modestly from $46.8M in 2025-Q4 to $47.7M in 2026-Q1. Operating income improved significantly from a loss of $18.5M in 2025-Q4 to a positive $1.5M in 2026-Q1. Management's guidance and results show delivering trajectory on revenue and EBITDA above guidance. Delivery assessment Oct 24, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPSUnavailable

Unavailable → Unavailable · observed estimates

FY2027 revenue$0.19B

$0.22B → $0.19B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	Unavailable	$218,857,683	3 / 5
2026-07-25	Unavailable	$218,857,683	3 / 5
2026-07-26	Unavailable	$218,857,683	3 / 5
2026-07-27	Unavailable	$218,857,683	3 / 5
2026-07-28	$0.23	$218,857,670	5 / 6
2026-07-29	Unavailable	$218,857,683	3 / 5
2026-07-30	Unavailable	$218,857,683	3 / 5
2026-07-31	$0.23	$218,857,670	5 / 6
2026-08-01	Unavailable	$218,857,683	3 / 5
2026-08-02	$0.23	$218,857,670	5 / 6
2026-08-03	Unavailable	$218,857,683	3 / 5
2026-08-04	$0.23	$218,857,670	5 / 6
2026-08-05	Unavailable	$218,857,683	3 / 5
2026-08-06	Unavailable	$218,857,683	3 / 5
2026-08-08	Unavailable	$218,857,683	3 / 5
2026-08-09	$0.23	$218,857,670	5 / 6
2026-08-10	Unavailable	$218,857,683	3 / 5
2026-08-12	Unavailable	$218,857,683	3 / 5
2026-08-13	Unavailable	$218,857,683	3 / 5
2026-08-14	Unavailable	$218,857,683	3 / 5
2026-08-15	Unavailable	$218,857,683	3 / 5
2026-08-16	Unavailable	$218,857,683	3 / 5
2026-08-17	Unavailable	$218,857,683	3 / 5
2026-08-18	Unavailable	$218,857,683	3 / 5
2026-08-19	Unavailable	$218,857,683	3 / 5
2026-08-20	Unavailable	$196,459,150	3 / 5
2026-08-21	Unavailable	$196,459,150	3 / 5
2026-08-22	Unavailable	$196,459,150	3 / 5
2026-08-23	Unavailable	$196,459,150	3 / 5
2026-08-24	Unavailable	$192,110,980	3 / 5
2026-08-25	Unavailable	$192,110,980	3 / 5
2026-08-26	Unavailable	$192,110,980	3 / 5
2026-08-27	Unavailable	$192,110,980	3 / 5
2026-08-28	Unavailable	$192,110,980	3 / 5
2026-08-29	Unavailable	$192,110,980	3 / 5
2026-08-30	Unavailable	$192,110,980	3 / 5
2026-08-31	Unavailable	$192,110,980	3 / 5
2026-09-01	Unavailable	$192,110,980	3 / 5
2026-09-02	Unavailable	$192,110,980	3 / 5
2026-09-03	Unavailable	$192,110,980	3 / 5
2026-09-04	Unavailable	$192,110,980	3 / 5
2026-09-05	Unavailable	$192,110,980	3 / 5
2026-09-06	Unavailable	$192,110,980	3 / 5
2026-09-07	Unavailable	$192,110,980	3 / 5
2026-09-08	Unavailable	$192,110,980	3 / 5
2026-09-09	Unavailable	$192,110,980	3 / 5
2026-09-10	Unavailable	$192,110,980	3 / 5
2026-09-11	Unavailable	$191,992,483	3 / 5
2026-09-12	Unavailable	$191,992,483	3 / 5
2026-09-13	Unavailable	Unavailable	3 / 4
2026-09-14	Unavailable	Unavailable	3 / 4
2026-09-15	Unavailable	Unavailable	3 / 4
2026-09-16	Unavailable	$191,992,483	3 / 5
2026-09-17	Unavailable	$191,992,483	3 / 5
2026-09-18	Unavailable	$191,992,483	3 / 5
2026-09-19	Unavailable	$191,992,483	3 / 5
2026-09-20	Unavailable	$191,992,483	3 / 5
2026-09-21	Unavailable	$191,992,483	3 / 5
2026-09-22	Unavailable	$191,992,483	3 / 5
2026-09-23	Unavailable	$191,992,483	3 / 5
2026-09-24	Unavailable	$191,992,483	3 / 5
2026-09-25	Unavailable	$191,992,483	3 / 5
2026-09-26	Unavailable	$191,992,483	3 / 5
2026-09-27	Unavailable	$191,992,483	3 / 5
2026-09-28	Unavailable	$191,992,483	3 / 5
2026-09-29	Unavailable	$191,992,483	3 / 5
2026-09-30	Unavailable	$191,992,483	3 / 5
2026-10-01	Unavailable	$191,992,483	3 / 5
2026-10-02	Unavailable	$191,992,483	3 / 5
2026-10-03	Unavailable	$191,992,483	3 / 5
2026-10-04	Unavailable	$191,992,483	3 / 5
2026-10-05	Unavailable	$191,992,483	3 / 5
2026-10-06	Unavailable	$191,992,483	3 / 5
2026-10-07	Unavailable	$191,992,483	3 / 5
2026-10-08	Unavailable	$191,992,483	3 / 5
2026-10-09	Unavailable	$191,992,483	3 / 5
2026-10-10	Unavailable	$191,992,483	3 / 5
2026-10-11	Unavailable	$191,992,483	3 / 5
2026-10-12	Unavailable	$191,992,483	3 / 5
2026-10-13	Unavailable	$191,992,483	3 / 5
2026-10-14	Unavailable	$191,992,483	3 / 5
2026-10-15	Unavailable	$191,992,483	3 / 5
2026-10-16	Unavailable	$191,992,483	3 / 5
2026-10-17	Unavailable	$191,992,483	3 / 5
2026-10-18	Unavailable	$191,992,483	3 / 5
2026-10-19	Unavailable	$191,992,483	3 / 5
2026-10-20	Unavailable	$191,992,483	3 / 5
2026-10-21	Unavailable	$191,992,483	3 / 5
2026-10-22	Unavailable	$191,992,483	3 / 5
2026-10-23	Unavailable	$191,992,483	3 / 5
2026-10-24	Unavailable	$191,992,483	3 / 5

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	4	2
2026-06-01	4	2
2026-07-01	4	2
2026-08-01	4	2
2026-09-01	4	3
2026-10-01	3	3

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 3 Buy / Strong Buy · 3 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

EPS growth to $0.26 in FY27Published status: Broken
Revenue growth of about 15% next yearDirect metric needs a verified mapping

Next proof point

Nov 9, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

2.0%Typical daily move · historical

Downside history

-50.0%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Telos Corp. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

TLS is a high-risk recovery story, not yet a proven durable compounder, because the evidence still describes the business as loss-making. The long-term thesis is in a watch state: management priorities are on track, but recent performance remains below its industry cohort.

What's priced into Telos Corp.

The valuation signal is marked justified, with low fragility and an expectations gap close to neutral. TLS carries a premium versus peers, while its valuation score recently fell; this leaves limited evidence that the market is pricing in a clear bargain.

What the fundamentals likely do

Near-term results show mixed progress: revenue rose modestly, and operating income and net income improved from losses to positive results in 2026-Q1. Management priorities, including exceeding guidance and the CEO’s return, are marked on track, but an August earnings miss and performance below the industry cohort remain concerns.

What Telos Corp. hinges on

The multi-year thesis depends on management sustaining operating progress and delivering revenue and EBITDA above guidance. Near term, a guidance cut would weaken the case; rate cuts or stronger results and guidance from sector peers could support the business backdrop, though the evidence does not show that these outcomes are assured.